HYTEST
Anticancer, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 75352276 |
| Registration Number | 2261539 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Attorney Name | JENNIFER LEE TAYLOR |
| Attorney Docket Number | 31276-240340 |
| Law Office Assigned | L50 |
| Employee Name | JENKINS JR, CHARLES L |
Timeline
| 1997-09-05 | Application Filed |
| 1998-07-28 | Published for Opposition |
| 1999-04-13 | Date of First Use |
| 1999-07-13 | Trademark Registered |
| 2009-07-13 | Renewal Date |
| 2009-07-23 | Location: POST REGISTRATION |
| 2009-07-23 | Status: Live/Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  ANTICANCER, INC. |
| Address | 7917 Ostrow Street San Diego CA 92111 |
| Legal Entity Type | Corporation |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | chemical reagents for in vitro diagnosis of homocysteine in blood or urine for medical diagnostic purposes |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 1998-04-16 | 1 DOCK D:Assigned to Examiner |
| ASSIGNED TO EXAMINER | 1998-04-17 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 1998-04-24 | 3 CNRT F:First Action |
| EXAMINER'S AMENDMENT MAILED | 1998-05-18 | 4 CNEA F:First Action |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 1998-05-22 | 5 CNSA P: |
| NOTICE OF PUBLICATION | 1998-06-26 | 6 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 1998-07-28 | 7 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 1998-10-20 | 8 NOAM O:Outgoing Correspondence |
| USE AMENDMENT FILED | 1999-04-19 | 9 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 1999-05-14 | 10 SUPC I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 1999-05-20 | 11 DOCK D:Assigned to Examiner |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 1999-05-21 | 12 CNPR P: |
| REGISTERED-PRINCIPAL REGISTER | 1999-07-13 | 13 R.PR A:Allowance for Publication |
| TEAS SECTION 8 & 15 RECEIVED | 2005-07-12 | 14 E815 I:Incoming Correspondence |
| REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | 2005-07-12 | 15 815F I:Incoming Correspondence |
| ASSIGNED TO PARALEGAL | 2005-09-12 | 16 PLGL A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2005-09-13 | 17 C15A O:Outgoing Correspondence |
| CASE FILE IN TICRS | 2007-07-06 | 18 CFIT O:Outgoing Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2009-07-10 | 19 E89R I:Incoming Correspondence |
| ASSIGNED TO PARALEGAL | 2009-07-17 | 20 PLGL A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2009-07-23 | 21 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2009-07-23 | 22 RNL1 Q: |
| CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | 2021-10-29 | 23 CAEX O:Outgoing Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 